Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

NCT02919878 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma

Interventions

DRUG: Gemcitabine
RADIATION: XRT
DRUG: capecitabine

Sponsor

King Faisal Specialist Hospital & Research Center